Skip to main content
Equibles
ATR logo

ATR · Aptargroup, Inc.

Track ATR — free

Use ATR with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$127.41 -0.90 (-0.70%) At close · Sep 4
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$8.10B
Shares
63.58M

ATR metrics

94 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$127.41
Market cap
$8.10B

Price action

19 metrics
Price change (1W)
-4.2%
Price change (30D)
-6.2%
Price change (3M)
+12.4%
Price change (6M)
-3.5%
Price change (YTD)
+4.5%
Price change (1Y)
-8.0%
Trailing year
Price change (5Y)
-5.7%
52-week high
$145.72
52-week low
$111.94
Change from 52-week high
-12.6%
Change from 52-week low
+13.8%
Annualized volatility
24.4%
Beta
0.4
RSI (14D)
33.8
Price vs SMA 50
-2.9%
Price vs SMA 200
+0.7%
Avg volume (3M)
455,125
Relative volume
0.7
Average dollar volume
$58.46M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
63.58M

Valuation

12 metrics
P / E (TTM)
23.0
Trailing earnings · reciprocal yield 4.3%
PEG ratio
—
EV / revenue
2.1×
reciprocal yield 48.4%
EV / EBITDA
—
EV / EBIT
17.0×
reciprocal yield 5.9%
P / sales
2.1×
reciprocal yield 48.6%
P / book
3.1
reciprocal yield 32.4%
FCF yield
3.8%
TTM · current market cap
Buyback yield
4.5%
P / FCF
26.1
reciprocal yield 3.8%
P / operating cash flow
13.9
reciprocal yield 7.2%
Earnings yield
4.5%

Historical valuation

8 metrics
P / E historical average (3Y)
26.8×
reciprocal yield 3.7%
P / E historical average (5Y)
29.1×
reciprocal yield 3.4%
EV / revenue historical average (3Y)
2.8×
reciprocal yield 36.1%
EV / revenue historical average (5Y)
2.7×
reciprocal yield 36.6%
EV / EBIT historical average (3Y)
21.5×
reciprocal yield 4.6%
EV / EBIT historical average (5Y)
22.4×
reciprocal yield 4.5%
EV / EBITDA historical average (3Y)
14.2×
reciprocal yield 7.0%
EV / EBITDA historical average (5Y)
14.7×
reciprocal yield 6.8%

Dividends & buybacks

7 metrics
Dividend yield
1.5%
Trailing 12 months
Payout ratio
33.8%
Shareholder yield
6.0%
Dividend / share (TTM)
$1.92
Dividend growth YoY
+6.7%
Dividend growth streak
5
Last ex-dividend
2026-07-30

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-31

Profitability

9 metrics
Gross margin
—
Operating margin
12.1%
Trailing 12 months
Net margin
9.2%
Gross profit (TTM)
$906.01M
Operating profit (TTM)
$477.42M
Net income (TTM)
$362.52M
Trailing 12 months
Diluted EPS (TTM)
$5.53
FCF margin
7.9%
Effective tax rate
20.2%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
$13.59
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+6.3%
Year over year
Net income growth YoY
-21.6%
Revenue (TTM)
$3.93B
Trailing 12 months
EPS growth YoY
-18.6%
Shares change YoY
-4.2%
Year over year · fewer shares
Revenue CAGR (3Y)
+4.4%
Revenue CAGR (5Y)
+5.2%
EPS CAGR (3Y)
+17.9%
EPS CAGR (5Y)
+12.9%
FCF CAGR (3Y)
+21.2%
FCF CAGR (5Y)
-1.6%

Quality

14 metrics
Return on equity
13.8%
Return on assets
7.1%
Debt / equity
0.1
Current ratio
1.6
EBITDA (TTM)
—
Free cash flow (TTM)
$310.39M
Quick ratio
1.1
Interest coverage
7.5
Net debt / EBITDA
—
Return on invested capital
14.4%
Trailing 12 months
Net cash
−$20.27M
Latest balance sheet
Cash & equivalents
$190.40M
Total assets
$5.13B
Total debt
$217.54M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$583.48M
Capital expenditures (TTM)
$273.09M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$40.80M
R&D / revenue
—
Stock compensation / revenue
1.0%

Ownership (13F)

3 metrics
13F filers
555
13F filer change QoQ
+10
Institutional ownership
96.2%

Short interest

3 metrics
Short interest
2.5%
Latest settlement · 3.3 days to cover
Days to cover
3.3d
Short-squeeze score
49 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4.19M
Insider-sentiment score
17 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 896622 CUSIP 038336103 13F (30d) 343 filings 330 filers Visit website Investor relations